Robert C. Rickert

Robert C. Rickert

Auto-generated profile, based on publicly available information

Robert C. Rickert

Tumor Microenvironment and Cancer Immunology Program, National Cancer Institute designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 1

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
EMEllen J. McAllister
Ellen J. McAllister
JAJohn R. Apgar
John R. Apgar
CLCharlotte R. Leung
Charlotte R. Leung
RRRobert C. Rickert
Robert C. Rickert
JJJulia Jellusova
Julia Jellusova
B cells contribute critically to an effective immune response by producing Ag-specific Abs. During the immune response to so-called “thymus-dependent Ags,” activated B cells seek T cell help and form germinal centers. In contrast, thymus-independent Ags generally do not induce germinal center formation. In the germinal center, B cells undergo somatic hypermutation, affinity-based clonal expansion, and differentiation to produce plasma cells and memory B cells. Valuable insight into these processes has been gained by using model hapten–carrier complexes or SRBCs. SRBCs induce robust germinal center formation in mice. Therefore, this Ag is commonly used to study germinal center responses. In contrast to haptenated Ags, thus far it has been difficult to measure the titer of Ag-specific Abs or the expansion of Ag-specific B cells after immunization with SRBCs. We have developed new, simple methods to access these parameters, thus providing new tools to study germinal center and Ab responses.

2 April 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
NBNumana Bhat
Numana Bhat
RVRichard Virgen-Slane
Richard Virgen-Slane
PRParham Ramezani-Rad
Parham Ramezani-Rad
CLCharlotte R. Leung
Charlotte R. Leung
CCCindi Chen
Cindi Chen
RRRobert C. Rickert
Robert C. Rickert
Regnase-1 is an emerging regulator of immune responses with essential roles in the posttranscriptional control of immune cell activation. Regnase-1 is expressed in B cells; however, its B cell–specific functions remain unknown. Here, we demonstrate that Regnase-1 prevents severe autoimmune pathology and show its essential role in maintaining B cell homeostasis. Using Cre driver mice for ablation of Regnase-1 at various stages of B cell development, we demonstrate that loss of Regnase-1 leads to aberrant B cell activation and differentiation, resulting in systemic autoimmunity and early morbidity. The basis of these findings was informed by gene expression data revealing a regulatory role for Regnase-1 in the suppression of a transcriptional program that promotes B cell activation, survival, and differentiation. Overall, our study shows that Regnase-1 exerts critical control of B cell activation, which is required for prevention of immunopathology.

1 October 2019 in ImmunoHorizons
Verified
Journal Article
Open access
PDF file
JDJoseph Dekker
Joseph Dekker
GBGisele V. Baracho
Gisele V. Baracho
ZZZilu Zhu
Zilu Zhu
Gregory C. IppolitoGregory C. Ippolito
Gregory C. Ippolito
RSRobert J. Schmitz
Robert J. Schmitz
HTHaley Tucker
Haley Tucker
The FOXP1 transcription factor is expressed throughout B cell development until its extinction just prior to terminal differentiation. Foxp1 nulls die of cardiac defects at midgestation, but adult rescue via fetal liver transfer led to a strong pre–B cell block. To circumvent these limitations and to investigate FOXP1 function at later stages of B cell differentiation, we generated and analyzed floxed (F) Foxp1 alleles deleted at pro–B, transitional (T) 1, and mature B cell stages. Mb-1cre–mediated deletion of Foxp1F/F confirmed its requirement for pro–B to pre–B transition. Cd21- and Cd19cre deletion led to significant reduction of germinal center formation and a second block in differentiation at the T2/marginal zone precursor stage. T-dependent and -independent immunization of FOXP1 mutants led to reduction of Ag-specific IgM, whereas responses of class-switched Abs were unimpaired. Yet, unexpectedly, plasmablast and plasma cell numbers were significantly increased by in vitro BCR stimulation of Foxp1F/F splenic follicular B cells but rapidly lost, as they were highly prone to apoptosis. RNA sequencing, gene set enrichment analysis, and chromatin immunoprecipitation sequencing analyses revealed strong enrichment for signatures related to downregulation of immune responses, apoptosis, and germinal center biology, including direct activation of Bcl6 and downregulation of Aicda/AID, the primary effector of somatic hypermutation, and class-switch recombination. These observations support a role for FOXP1 as a direct transcriptional regulator at key steps underlying B cell development in the mouse.